A better understanding of the immune system’s role in eos asthma could help scientists develop treatments.
The genes involved with eos asthma can help provide clues as to how the condition might be prevented.
Biomarkers are molecules such as genes, hormones or proteins. These can help doctors diagnose a disease. High counts of eosinophils in the blood are one possible biomarker for eos asthma. Biomarkers can help us predict which treatments might be more effective for a person who has eos asthma.
Clinical trials for eos asthma are currently underway. Many of these studies focus on new medicines to control asthma symptoms.
There are many advantages to participating in a trial. One advantage is that you receive medical care from providers experienced with the condition. You also might have the chance to try new medicines that are being developed.
Studies enrolling for eosinophilic asthma are posted to ClinicalTrials.gov.